IP Library › Granted Patent US 7,081,562
Granted Patent B1
US 7,081,562 · App. 10/148,413 · Granted Jul 25, 2006

Model animal with favorite onset or rheumatoid arthritis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,081,562
App. No.
10/148,413
Granted
Jul 25, 2006
Kind
B1
Abstract

The present invention provides a model animal with favorite onset of rheumatoid arthritis wherein the severity of arthritis reaches the maximum level and its onset ratio is a hundred percent, and a screening method of a remedy for rheumatoid arthritis by using the model animal. A mouse whose function of immunoglobulin Fcγ receptor IIB gene is deficient on its chromosome and a wild-type collagen-induced arthritis-susceptible DBA/1J mouse are backcrossed six times or more, and a model mouse with favorite onset of rheumatoid arthritis is constructed. This model mouse with favorite onset of rheumatoid arthritis is immunized with bovine joint-origin type II collagen to develop collagen-induced arthritis.

Claims (9)

1. A mouse model with favorite onset of rheumatoid arthritis,

obtained by

(i) crossing a first mouse strain, having an inactivation of its endogenous immunoglobulin Fcγ receptor IIB gene, with a second mouse strain, wherein said second mouse strain is a wild-type collagen-induced arthritis-susceptible mouse strain, to obtain a mouse having a heterozygous inactivation of its endogenous immunoglobulin Fcγ receptor IIB gene, and

(ii) performing one or more backcrosses, wherein the first backcross is carried out by breeding the heterozygous mouse obtained in step (i) with said second mouse strain to obtain a mouse having a heterozygous inactivation of its endogenous immunoglobulin Fcγ receptor IIB gene, and

(iii) intercrossing the heterozygous mice obtained in the last backcross of the one or more backcrosses to produce a mouse having a homozygous inactivation of its endogenous immunoglobulin Fcγ receptor IIB gene, wherein onset of collagen-induced arthritis is observed when said mouse having a homozygous inactivation of its endogenous immunoglobulin Fcγ receptor IIB gene is immunized with type II collagen, thereby producing a mouse model with favorite onset of rheumatoid arthritis.

2. The model mouse with favorite onset of rheumatoid arthritis according to claim 1 , wherein said second mouse strain is a wild-type DBA/1J mouse.

3. The model mouse with favorite onset of rheumatoid arthritis according to claim 1 or 2 , wherein backcrossing is conducted eight times or more.

4. The model mouse with favorite onset of rheumatoid arthritis according to claim 1 or 2 , wherein the type II collagen is a bovine joint-origin type II collagen.

5. The model mouse with favorite onset of rheumatoid arthritis according to claim 3 , wherein the type II collagen is a bovine joint-origin type II collagen.